A Brief History of Medical Cannabis and Cannabinoids in the U.S.

The Ayurvedic Medicine Materia Medica Since the late 1940s and early 1950s, both state and federal entities have assiduously avoided treating cannabis as the medicine it has been for over 4,000 years. Cannabis has been recognized as a medicine since at least 2637 B.C.E. when it was included in the first known pharmacopoeia, the Ping Ts’ao Ching, alleged to be written by the second Emperor of China, Shen Neng. Cannabis has appeared in all subsequent major pharmacopoeias including an Ayurvedic Medicine Materia Medica, dated from between 1100 B.C.E. and 1700 B.C.E., as well as the Ebers Papy...
More

Who We Are

The AACM is a clinical medicine, scientific association. Its members are clinicians and researchers active in the field of endogenous, plant-derived and synthetic cannabinoids and those who support the medical use of cannabinoids. It is the gold standard for the education and dissemination of clinically relevant information in the emerging field of cannabinoid and endocannabinoid medicine. Our focus is on the application of clinical and physiological studies of cannabinoids and the endocannabinoid system. We provide professional and legal support in the field of cannabinoid medicine. We ed...
More

The Systemic Lack of Education About the Endocannabinoid System Leads to Widespread Ignorance About Cannabis

by David Bearman, M.D. The lack of education from grade school through grad school and medical school regarding cannabis, cannabinoids and the endocannabinoid system (ECS) is directly a result of bad policy. Up and down this is due to the government dealing with many psychoactive substances on a criminal justice basis not as medicine and not following the science.  Much of education problem can be traced to our medical schools. The majority of U.S medical schools are not even addressing the ECS, arguably the largest neurotransmitter system in the human brain, let alone the med...
More

Quality vs. Junk Science: Read the Study, Not Just the Headline

The United States is in an epidemic; there are too many people rejecting real science while embracing junk. This is not an isolated phenomenon, it applies to global warming, disease prevention and policy toward substance use and abuse. Just because a study has been done doesn’t mean it is a well-designed, valid study. One needs to look beyond the alleged results and look at the design. We need to look at the results with a critical eye toward such matters as study design and raw data, and how the data has been integrated. When you read a new headlines about a study ask questions. Is i...
More

Who We Are

The AACM is a clinical medicine, scientific association. Its members are clinicians and researchers active in the field of endogenous, plant-derived and synthetic cannabinoids and those who support the medical use of cannabinoids. It is the gold standard for the education and dissemination of clinically relevant information in the emerging field of cannabinoid and endocannabinoid medicine. Our focus is on the application of clinical and physiological studies of cannabinoids and the endocannabinoid system. We provide professional and legal support in the field of cannabinoid medicine. We edu...
More